Clinical Trial Update: Carbamazapine for Inherited Erythromelalgia Patients With NaV1.7 Mutations [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating carbamazepine for inherited erythromelalgia in patients with NaV1.7 mutations; the study completed and results were pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erythromelalgia

Drugs mentioned

• Carbamazepine (Carbamazepine)

Snippet

Sponsor: VA Connecticut Healthcare System | Conditions: Erythromelalgia | Phase 4 | Status: COMPLETED | Results posted: 2017-06-06